Late-onset hypogonadism and mortality in aging men

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 4, 2014, Pages 1357-1366

  Pye, S R ^a   Huhtaniemi, I T ^b   Finn, J D ^a   Lee, D M ^a   O'Neill, T W ^a   Tajar, A ^a   Bartfai, G ^c   Boonen, S ^d   Casanueva, F F ^g   Forti, G ^h   Giwercman, A ⁱ   Han, T S ^j   Kula, K ^k   Lean, M E ^a   Pendleton, N ^l   Punab, M ^l   Rutter, M K ^a   Vanderschueren, D ^d,e,f   Wu, F C W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SZEGED   (Hungary)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

^g UNIVERSITY OF FLORENCE   (Italy)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j MEDICAL UNIVERSITY OF LODZ   (Poland)

^k UNIVERSITY OF GLASGOW   (United Kingdom)

^l TARTU UNIVERSITY CLINICS   (Estonia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE OF ONSET; AGED; AGING; CARDIOVASCULAR DISEASES; EUROPE; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; TESTOSTERONE;

EID: 84895470561     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2052     Document Type: Article

References (41)

1. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: lon-gitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87:589-598.
2. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab . 2001;86:724-731.
3. Wu FC. Commentary: Guideline for male testosterone therapy: a European perspective. J Clin Endocrinol Metab. 2007;92:418-419.
4. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:2536-2559.
5. Cunningham GR, Toma SM. Why is androgen replacement in males controversial? J Clin Endocrinol Metab . 2011;96:38-52.
6. Swerdloff R, Wang C. Testosterone treatment of older men-why are controversies created? J Clin Endocrinol Metab. 2011; 96:62-65.
7. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010; 363:123-135.
8. Tajar A, Huhtaniemi IT, O'Neill TW, et al. Characteristics of an-drogen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab . 2012; 97:1508-1516.
9. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96:3007-3019.
10. Ruige JB, Mahmoud AM, DeBacquerD, Kaufman JM. Endogenous testosterone and cardiovascular disease in healthy men: a meta-anal-ysis. Heart. 2011;97:870-875.
11. Corona G, Rastrelli G, Monami M, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol. 2011;165:687-701.
12. Araujo AB, Travison TG, Ganz P, et al. Erectile dysfunction and mortality. J Sex Med. 2009;6:2445-2454.
13. Corona G, Monami M, Boddi V, et al. Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction. J Sex Med. 2010;7:1557-1564.
14. Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2011;58:1378-1385.
15. Lee DM, O'Neill TW, Pye SR, et al. The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl. 2009;32:11-24.
16. Labrie F, Belanger A, Belanger P, et al. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol. 2006;99:182-188.
17. Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. JClin En-docrinol Metab. 2008;93:2737-2745.
18. Lee DM, Rutter MK, O'Neill TW, et al. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol. 2009;161:947-954.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and /3-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
20. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med. 2006; 166:1660-1665.
21. Khaw KT, Dowsett M, Folkerd E, et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation. 2007; 116:2694-2701.
22. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. JClin Endocrinol Metab. 2008; 93:68-75.
23. Lehtonen A, Huupponen R, Tuomilehto J, et al. Serum testosterone but not leptin predicts mortality in elderly men. Age Ageing. 2008; 37:461-464.
24. Tivesten A, Vandenput L, Labrie F, et al. Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metab. 2009;94:2482-2488.
25. Vikan T, Schirmer H, Njolstad I, Svartberg J. Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromso Study. Eur J Endocrinol. 2009; 161:435-442.
26. Haring R, Volzke H, Steveling A, et al. Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur Heart J. 2010;31:1494-1501.
27. Hyde Z, Norman PE, Flicker L, et al. Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men Study. J Clin Endocrinol Metab. 2012;97:179-189.
28. Smith GD, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman S, El-wood P. Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation. 2005;112: 332-340.
29. Araujo AB, Kupelian V, Page ST, Handelsman DJ, Bremner WJ, McKinlay JB. Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med. 2007;167:1252-1260.
30. Maggio M, Lauretani F, Ceda GP, et al. Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. Arch Intern Med. 2007;167:2249-2254.
31. Szulc P, Claustrat B, Delmas PD. Serum concentrations of 17/3-E2 and 25-hydroxycholecalciferol (25OHD) in relation to all-cause mortality in older men-the MINOS study. Clin Endocrinol (Oxf).
32. 2009;71:594-602.
33. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev. 2003;24:313-340.
34. Wu FC, von Eckardstein A. Androgens and coronary artery disease. Endocr Rev. 2003;24:183-217.
35. Yeap BB. Androgens and cardiovascular disease. Curr Opin Endo-crinol Diabetes Obes. 2010;17:269-276.
36. Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87:766-778.
37. Miner MM. Erectile dysfunction: a harbinger or consequence: does its detection lead to a window of curability? J Androl. 2011;32: 125-134.
38. Shores MM, Smith NL, Forsberg CW, Anawalt BD, Matsumoto AM. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab. 2012;97:2050-2058.
39. Wu FC. Caveat emptor: does testosterone treatment reduce mortality in men? J Clin Endocrinol Metab. 2012;97:1884-1886.
40. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309:71-82.
41. Lee DM, Pye SR, Tajar A, et al. Cohort profile: the European Male Ageing Study. Int J Epidemiol. 2013;42(2):391-401.